Q2 2022 13F Holders as of 6/30/2022
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
129M
-
Number of holders
-
216
-
Total 13F shares, excl. options
-
117M
-
Shares change
-
+6.36M
-
Total reported value, excl. options
-
$956M
-
Value change
-
+$3.71M
-
Put/Call ratio
-
0.33
-
Number of buys
-
112
-
Number of sells
-
-127
-
Price
-
$8.15
Significant Holders of NEOGENOMICS INC - Common Stock, $0.01 par value (NEO) as of Q2 2022
287 filings reported holding NEO - NEOGENOMICS INC - Common Stock, $0.01 par value as of Q2 2022.
NEOGENOMICS INC - Common Stock, $0.01 par value (NEO) has 216 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 117M shares
of 129M outstanding shares and own 90.71% of the company stock.
Largest 10 shareholders include BlackRock Inc. (21M shares), VANGUARD GROUP INC (13.3M shares), WELLINGTON MANAGEMENT GROUP LLP (6.52M shares), BROWN ADVISORY INC (5.77M shares), STATE STREET CORP (4.1M shares), Assenagon Asset Management S.A. (3.61M shares), GOLDMAN SACHS GROUP INC (3.42M shares), First Light Asset Management, LLC (2.72M shares), FEDERATED HERMES, INC. (2.68M shares), and SCHRODER INVESTMENT MANAGEMENT GROUP (2.3M shares).
This table shows the top 216 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.